We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FOXX:NASDAQFoxx Development Holdings Inc. Analysis

Data as of 2026-04-04 - not real-time

$5.61

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Foxx Development Holdings is trading in a precarious technical environment. The short‑term moving averages sit beneath the current price, while the 20‑day SMA is still below the longer‑term averages, signaling a bearish trend, and the RSI has climbed into overbought territory, suggesting limited upside momentum. High beta and extreme 30‑day volatility amplify price swings, and the stock is flirting with a well‑defined resistance level that has capped recent rallies. Meanwhile, fundamental indicators are weak: earnings are negative, margins are deep in the red, and the balance sheet carries substantial debt against a modest cash cushion, resulting in a negative book value and a negative price‑to‑book ratio. Despite these challenges, the discounted cash flow model points to a fair value above the current market price, hinting at modest upside potential if cash flow trends improve.
The recent insider sale by the CTO adds a subtle negative sentiment, though the transaction size is modest relative to market cap. Given the blend of bearish technical signals, elevated risk metrics, and a valuation that appears slightly undervalued relative to DCF, the stock sits at a crossroads where short‑term pressure may dominate, but a longer‑term turnaround could be plausible if operational improvements materialize.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish moving‑average alignment
  • Overbought RSI and proximity to resistance
  • High volatility and beta amplifying downside risk

Medium Term

1–3 years
Neutral
Model confidence: 6/10

Key Factors

  • DCF indicates price upside potential
  • Negative earnings but positive free cash flow
  • Continued high volatility may limit upside

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential strategic turnaround could improve margins
  • Debt load remains a concern without clear repayment path
  • Valuation gap provides margin of safety if fundamentals improve

Key Metrics & Analysis

Financial Health

Revenue Growth-4.40%
Profit Margin-24.62%
ROA-14.81%
P/B Ratio-3.3
Op. Cash Flow$-2177478
Free Cash Flow$4.7M
Industry P/E33.5

Technical Analysis

TrendBearish
RSI68.8
Support$3.63
Resistance$5.64
MA 20$4.32
MA 50$4.60
MA 200$4.86
MACDBullish
VolumeStable
Fear & Greed Index78.8

Valuation

Fair Value$6.28
GradeUndervalued
TypeValue

Risk Assessment

Beta1.52
Volatility115.43%
Sector RiskMedium
Reg. RiskLow
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.